Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/17/2026

SOFA Score: Clinical Significance and Management

Introduction to SOFA Score

  • The Sequential Organ Failure Assessment (SOFA) score is a validated tool that evaluates dysfunction across six organ systems, with each system scored 0-4 points for a total possible score of 0-24, where higher scores indicate worse organ dysfunction and increased mortality risk, as recommended by the American College of Critical Care Medicine 1, 2

Core Components of SOFA-2

  • The respiratory system is assessed via PaO2/FiO2 ratio, ranging from 0 (≥400 mmHg) to 4 (<100 mmHg with mechanical ventilation), according to the Society of Critical Care Medicine 1, 3
  • The cardiovascular system is evaluated through mean arterial pressure and vasopressor requirements, from 0 (MAP ≥70 mmHg) to 4 (high-dose norepinephrine or epinephrine), as suggested by the American Heart Association 1

Clinical Significance by Score Range

  • A SOFA score of 2 indicates mild single-organ dysfunction and carries relatively low mortality risk in general ICU populations, as stated by the Society of Critical Care Medicine 1
  • In the presence of documented or suspected infection, a SOFA score increase of ≥2 points from baseline defines sepsis according to Sepsis-3 criteria, triggering immediate broad-spectrum antibiotics within 1 hour, fluid resuscitation, and source control, as recommended by the Surviving Sepsis Campaign 1, 2
  • Scores in the range of 7-10 indicate significant multi-organ dysfunction with substantially increased mortality risk, according to the American College of Critical Care Medicine 1
  • A SOFA score >10 predicts mortality exceeding 80-90%, with scores >11 associated with >90% mortality, as reported by the Society of Critical Care Medicine 1, 2

Management Algorithm Based on SOFA Score

  • Calculate SOFA score on ICU admission using the most abnormal values from the first 24 hours, as suggested by the American College of Critical Care Medicine 1, 2
  • Reassess SOFA scores every 48-72 hours throughout the ICU stay to track disease progression and treatment response, according to the Society of Critical Care Medicine 1

Critical Limitations and Pitfalls

  • Do not use SOFA alone for triage decisions in non-pandemic settings, as it lacks validation for resource allocation at low scores, as stated by the American College of Critical Care Medicine 1
  • SOFA does not consider patient age or comorbidities, unlike APACHE II scoring systems, as reported by the Society of Critical Care Medicine 1, 2, 3

Special Considerations for Mass Casualty Events

  • In anthrax or other mass-casualty incidents, mechanisms should capture SOFA scores and other objective scoring systems for septic patients, as recommended by the Centers for Disease Control and Prevention 4
  • Monitoring organ dysfunction over time is most useful; failure of clinical improvement or increasing scores across multiple organ systems indicates poor prognosis, according to the World Health Organization 4

Prognostic Utility in Research

  • SOFA is valuable for research purposes, audit, and comparing outcomes across different ICU populations, as stated by the American College of Critical Care Medicine 1, 3
  • When using SOFA as a research endpoint, clearly define primary outcomes (mortality, organ dysfunction, length of stay) and establish standardized protocols for collecting physiological parameters, as recommended by the National Institutes of Health 3

SOFA Score Organ System Scoring Criteria and ACLF Grading

Organ System Scoring (Core Components)

  • The Sequential Organ Failure Assessment (SOFA) score evaluates dysfunction across six organ systems—respiratory, cardiovascular, neurologic, hepatic, renal, and coagulation—using specific clinical and biochemical parameters. 5

  • Cardiovascular scoring:

    • 0 points – mean arterial pressure (MAP) ≥ 70 mm Hg without vasopressors.
    • 4 points – requirement for high‑dose dopamine > 15 µg/kg/min or high‑dose epinephrine/norepinephrine.
    • Intermediate points reflect increasing vasopressor support. [6][7]
  • Neurologic (brain) scoring:

    • Assessed with the Glasgow Coma Scale in general ICU patients or hepatic encephalopathy grade in cirrhotic patients.
    • 0 points – no encephalopathy (GCS 15).
    • 4 points – Grade IV hepatic encephalopathy (or GCS ≤ 6). [6][7]
  • Hepatic (liver) scoring:

    • Based on serum bilirubin concentration.
    • 0 points – bilirubin < 1.2 mg/dL.
    • 4 points – bilirubin ≥ 12.0 mg/dL. [6][7]
  • Renal (kidney) scoring:

    • Based on serum creatinine concentration.
    • 0 points – creatinine < 1.2 mg/dL.
    • 4 points – creatinine ≥ 5.0 mg/dL. [6][7]
  • Coagulation (hemostasis) scoring:

    • Uses platelet count and international normalized ratio (INR).
    • 0 points – INR < 1.1 (platelets > 150 × 10⁹/L).
    • 4 points – INR ≥ 2.5 or platelets ≤ 20 × 10³/L. [6][7]

Adaptation for Cirrhosis – CLIF‑SOFA and ACLF Grading

  • The CLIF‑SOFA score adapts the standard SOFA for patients with chronic liver disease and forms the basis for diagnosing and grading acute‑on‑chronic liver failure (ACLF). [6][7]

  • ACLF Grade Ia: Single renal failure defined by creatinine ≥ 2 mg/dL. [6][7]

  • ACLF Grade Ib: Single non‑renal organ failure together with mild renal dysfunction (creatinine 1.5–1.9 mg/dL) and/or hepatic encephalopathy grade I–II. [6][7]

  • ACLF Grade II: Failure of two organ systems; associated 28‑day mortality ≈ 32 %. [6][7]

  • ACLF Grade III: Failure of three or more organ systems; associated 28‑day mortality ≈ 78 %. [6][7]

REFERENCES

1

Organ Dysfunction Assessment in Critical Illness [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Sequential Organ Failure Assessment for Sepsis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Prognostic Tools for Critically Ill Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025